Jasper Therapeutics, Inc. · NASDAQ:JSPR
Goldman Sachs Group Inc's stake in Jasper Therapeutics, Inc. fell to 0.50% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 8, 2026
Goldman Sachs Group Inc's stake in Jasper Therapeutics, Inc. fell to 0.50%, 128,862 shares, as a passive investor on Mar 31, 2026. Filed May 8, 2026 (Schedule 13G/A).
- Stake
- 0.50%
- Shares
- 128,862
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| THE GOLDMAN SACHS GROUP, INC. | 0.50% | 128,862 |
| GOLDMAN SACHS & CO. LLC | 0.50% | 128,862 |
Source
Related
- Jasper Therapeutics, Inc.
- Goldman Sachs Group Inc
- Jasper Therapeutics, Inc. shareholders
- Schedule 13G · Goldman Sachs Group Inc · Feb 12, 2026
- Schedule 13G · Velan Capital Investment Management LP · Aug 17, 2026
- Schedule 13D/A · Velan Capital Investment Management LP · Jul 20, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 10, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · May 8, 2026